China Approves Its Homegrown COVID-19 Vaccine For Widespread Use
The state-owned Sinopharm says its vaccine has a 79% efficacy rate — surpassing the widely accepted standard of 50% efficacy.
(Image credit: Zhang Yuwei/Xinhua News Agency/Getty Images)
